First approved for type 2 diabetes treatment, GLP-1s are also FDA-approved for obesity
Given the costs, it may not be surprising that 51% of those familiar with GLP-1s believe only wealthy people can afford Ozempic or similar drugs for weight loss, while 21% disagree and 28% are neutral
( 5%9% with GLP-1 serious RAs vs~4%7% with placebo) However, they reduce all cause death from a number of chronic diseases, making them a great advance that reduces human suffering, economic costs of disease and increasing longevity
Drug patents last 20 years, but that time frame includes the many years it takes to test a drug before its brought to market
You'll always be the first to get the latest news about specials, promotions, and exciting new offers when you sign up for our monthly email or SMS/text updates